Pfizer released data from several studies showing that nirmatrelvir, the active main protease inhibitor of the company's antiviral combination therapy...
The Dual-Site Study Will Be Conducted at the Hannover Medical School in Germany, and Israel’s Tel-Aviv Sourasky Medical Center TEL AVIV, Israel, Jan....
The State of Virginia is the latest U.S. jurisdiction to attempt to reprioritize psychedelic substances under state law, including psilocybin, MDMA, and...
Żabka Group is now the largest chain of autonomous stores in Europe after launching 25 AI-powered stores called Żabka Nano. The innovative concept...
The article KGK Science Response to Health Canada’s announced changes to the Special Access Program (SAP) was originally published on Microdose. Health...
The year of 2021 proved to be an excellent year for Vancouver-based Gold Mountain Mining Corp (TSXV: GMTN). The company The post Gold Mountain Mining:...
Chinese scientists recently reported the key role of histone acetylation-regulated long noncoding RNA termed as lysosome cell death regulator (LCDR) in...
“Omicron, with its extraordinary, unprecedented degree of efficiency of transmissibility, will, ultimately, find just about everybody,” Dr. Anthony...
Proof-of-concept preclinical research begun on PharmAla’s patented novel drugs VANCOUVER, BC, Jan. 17, 2022 /CNW/ – PharmAla Biotech Holdings...
VERNON, BC, Jan. 13, 2022 /CNW/ – Doseology Sciences Inc. (CSE: MOOD) (“Doseology” or the “Company”) announces the appointment of Maryam...
The founder of Blossom breaks apart a recent study on the process of synthesizing MDMA in this monthly column. The post MAPS Publishes Open Science Approach...
The article Psychedelic Stocks to Watch in 2022 was originally published on Microdose. It was a wild 2021. We had NASDAQ uplists and multi-billion dollar...
MYND Life Sciences Inc. (CSE: MYND) (OTC: MYNDF) a biopharmaceutical research and development company creating innovative precision medicines for patients...
Pharmacists are the most accessible healthcare professionals to the general public. In the event of FDA approval of psychedelic medicine for anxiety, depression,...
Truffle Report has compiled a roundup of major psychedelic business news stories from the week of January 10-14, making it easier for you to access these...
The rush to business maturity for the psychedelics industry has led to inevitable comparisons to the growth and development of the cannabis industry. Both...
